Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials

Matthew P. Goetz, Meena Okera, Hans Wildiers, Mario Campone, Eva Maria Grischke, Luis Manso, Valérie A.M. André, Nadia Chouaki, Belén San Antonio, Masakazu Toi, George W. Sledge

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials'. Together they form a unique fingerprint.

Medicine & Life Sciences